Cargando…
SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL
BACKGROUND: Renal fibrosis is the final development pathway and the most common pathological manifestation of chronic kidney disease. Epigenetic alteration is a significant intrinsic factor contributing to the development of renal fibrosis. SET domain‐containing 2 (SETD2) is the sole histone H3K36 t...
Autores principales: | Liu, Changwei, Ni, Li, Li, Xiaoxue, Rao, Hanyu, Feng, Wenxin, Zhu, Yiwen, Zhang, Wei, Ma, Chunxiao, Xu, Yue, Gui, Liming, Wang, Ziyi, Aji, Rebiguli, Xu, Jin, Gao, Wei‐Qiang, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629155/ https://www.ncbi.nlm.nih.gov/pubmed/37933774 http://dx.doi.org/10.1002/ctm2.1468 |
Ejemplares similares
-
Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway
por: Ma, Chunxiao, et al.
Publicado: (2023) -
SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling
por: Li, Xiaoxue, et al.
Publicado: (2021) -
The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis
por: Liu, Min, et al.
Publicado: (2021) -
SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer
por: Rao, Hanyu, et al.
Publicado: (2023) -
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling
por: Zhou, Jun, et al.
Publicado: (2021)